Arcus Biosciences (RCUS) Prepaid Assets (2017 - 2026)
Arcus Biosciences' quarterly Prepaid Assets came in at $19.0 million in Q1 2026, little changed year-on-year from $19.0 million in Q1 2025, and up 26.67% quarter-over-quarter from $15.0 million in Q4 2025.
Arcus Biosciences has reported Prepaid Assets for 10 years, with the latest figure at $19.0 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets changed 0.0% year-over-year to $19.0 million; the trailing twelve-month figure through Mar 2026 stood at $19.0 million (changed 0.0% YoY), and the FY2025 full-year result was $15.0 million, down 16.67% from the prior year.
- Prepaid Assets for Q1 2026 stood at $19.0 million, up from $15.0 million in the prior quarter.
- The five-year high for Prepaid Assets was $34.0 million in Q4 2023, with the low at $15.0 million in Q3 2025.
- Average Prepaid Assets over 5 years is $22.2 million, with a median of $20.0 million recorded in 2025.
- Year-over-year, Prepaid Assets surged 113.44% in 2022 and slumped 47.06% in 2024.
- Tracing RCUS's Prepaid Assets over 5 years: stood at $19.0 million in 2022, then jumped by 78.95% to $34.0 million in 2023, then tumbled by 47.06% to $18.0 million in 2024, then decreased by 16.67% to $15.0 million in 2025, then gained by 26.67% to $19.0 million in 2026.
- The last three Prepaid Assets figures came in at $19.0 million (Q1 2026), $15.0 million (Q4 2025), and $15.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Arcus Biosciences | 3.18 Bn | 2.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.00 Mn |
| Dec 31, 2025 | 15.00 Mn |
| Sep 30, 2025 | 15.00 Mn |
| Jun 30, 2025 | 20.00 Mn |
| Mar 31, 2025 | 19.00 Mn |
| Dec 31, 2024 | 18.00 Mn |
| Sep 30, 2024 | 22.00 Mn |
| Jun 30, 2024 | 25.00 Mn |
| Mar 31, 2024 | 34.00 Mn |
| Dec 31, 2023 | 34.00 Mn |
| Sep 30, 2023 | 31.00 Mn |
| Jun 30, 2023 | 22.00 Mn |
| Mar 31, 2023 | 28.00 Mn |
| Dec 31, 2022 | 19.00 Mn |
| Sep 30, 2022 | 21.63 Mn |
| Jun 30, 2022 | 15.67 Mn |
| Mar 31, 2022 | 18.53 Mn |
| Dec 31, 2021 | 18.00 Mn |
| Sep 30, 2021 | 17.57 Mn |
| Jun 30, 2021 | 21.97 Mn |
| Mar 31, 2021 | 8.68 Mn |
| Dec 31, 2020 | 5.47 Mn |
| Sep 30, 2020 | 11.82 Mn |
| Jun 30, 2020 | 8.67 Mn |
| Mar 31, 2020 | 8.01 Mn |
| Dec 31, 2019 | 4.05 Mn |
| Sep 30, 2019 | 4.22 Mn |
| Jun 30, 2019 | 3.27 Mn |
| Mar 31, 2019 | 3.08 Mn |
| Dec 31, 2018 | 2.32 Mn |
| Sep 30, 2018 | 2.33 Mn |
| Jun 30, 2018 | 1.55 Mn |
| Mar 31, 2018 | 1.83 Mn |
| Dec 31, 2017 | 1.14 Mn |